Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-01-08FDA Approved: CLADRIBINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Cladribine from Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS) [Phase 2]
This Phase 2 trial compares two doses of ABT-874 to placebo in individuals with multiple sclerosis. It reports on safety and effectiveness o…
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis [Phase 2]
This Phase 2 study update reports long-term safety of adding teriflunomide to interferon-beta or glatiramer acetate in patients with multipl…
-
FDA approval · 2012-12-21FDA Approved: AMPYRA — Supplemental Application (Merz Pharmaceuticals, LLC)
The FDA approved a supplemental application for AMPYRA (dalfampridine) filed by Merz Pharmaceuticals, LLC. This action updates the regulator…
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial evaluating whether Vitamin D supplementation can reduce relapse rates in patients with multiple sclerosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-12-11FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for Betaseron (interferon beta-1b) from Bayer HealthCare Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: The Efficacy of EMDR in Patients With PTSD in Multiple Sclerosis [Phase 3]
Phase 3 clinical trial evaluating EMDR therapy for posttraumatic stress disorder symptoms in people with multiple sclerosis; current status …
-
FDA approval · 2012-12-05FDA Approved: MITOXANTRONE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
The FDA approved a supplemental application for mitoxantrone from Meitheal Pharmaceuticals Inc., updating the approved generic product under…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis [Phase 3]
This update reports that a Phase 3 randomized trial evaluating Interferon beta for intermediate uveitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients [Phase 2]
Phase 2 trial evaluating interferon-alpha in multiple sclerosis patients with neutralizing antibodies to interferon-beta; the study status i…
-
FDA approval · 2012-11-28FDA Approved: TIZANIDINE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved Unichem Pharmaceuticals (USA), Inc.'s original abbreviated new drug application for tizanidine, a generic muscle relaxant. This…
-
CLINICAL_TRIALS trial_result · 2012-11-22Clinical Trial Update: Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
This update reports 16-year long-term follow-up data for Betaseron in patients with relapsing-remitting multiple sclerosis, highlighting lon…
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers [Phase 1]
This Phase 1 trial in healthy volunteers evaluated the bioequivalence of interferon beta-1a produced by two different manufacturing processe…
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Combination Therapy Using Cellcept and Rebif in RRMS [EARLY_Phase 1]
The document reports an early-phase 1 clinical trial examining the combination of Cellcept (mycophenolate mofetil) and Rebif (interferon bet…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri [Phase 4]
Phase 4 clinical trial update on MRI follow-up of macrophagic infiltration in multiple sclerosis patients treated with natalizumab (Tysabri)…
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis [Phase 3]
Phase 3 clinical trial results for teriflunomide in relapsing forms of multiple sclerosis, reporting relapse reduction and disability outcom…
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis [Phase 3]
A Phase 3 clinical trial update comparing the effectiveness and safety of teriflunomide versus interferon beta-1a in relapsing multiple scle…
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis [Phase 1]
This Phase 1 study completed evaluating the pharmacokinetics and immunologic effects of alpha-lipoic acid in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis [Phase 2]
Phase II trial evaluating teriflunomide as adjunct to interferon-beta in multiple sclerosis completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis [Phase 2]
Phase II study evaluating teriflunomide as adjunctive therapy to glatiramer acetate in multiple sclerosis; results completed with data poste…
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: Effect of Melatonin on Multiple Sclerosis Related Fatigue [Phase 2]
A Phase 2 trial evaluated melatonin for multiple sclerosis-related fatigue and has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis [Phase 2]
Phase 2 trial update on efficacy and safety of FTY720 (fingolimod) in relapsing multiple sclerosis completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia [Phase 2]
Phase 2 trial comparing an implanted neuroprosthesis with sensory training to improve airway protection in chronic dysphagia; results were p…
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Ginseng in Treatment of Fatigue in Multiple Sclerosis [Phase 2]
A Phase 2 trial evaluating ginseng for fatigue in people with multiple sclerosis has completed.
-
EMA guidance · 2012-10-09European Medicines Agency invites feedback on the draft guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis
EMA invites feedback on a draft guideline outlining clinical investigation considerations for medicinal products intended to treat multiple …